Revisiting the biological roles of PAI2 (SERPINB2) in cancer
Authors:
- David R. CroucherDCDavid R. Croucher
- Darren N. SaundersDSDarren N. Saunders
- Sergei LobovSLSergei Lobov
- Marie RansonMRMarie Ranson
- 12 June 2008
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 8 (7) , 535-545
Abstract
Tumour expression of the urokinase plasminogen activator correlates with invasive capacity. Consequently, inhibition of this serine protease by physiological inhibitors should decrease invasion and metastasis. However, of the two main urokinase inhibitors, high tumour levels of the type 1 inhibitor actually promote tumour progression, whereas high levels of the type 2 inhibitor decrease tumour growth and metastasis. We propose that the basis of this apparently paradoxical action of two similar serine protease inhibitors lies in key structural differences controlling interactions with components of the extracellular matrix and endocytosis-signalling co-receptors.Keywords
This publication has 148 references indexed in Scilit:
- Alteration in gene expression profile and biological behavior in human lung cancer cell line NL9980 by nm23-H1 gene silencingBiochemical and Biophysical Research Communications, 2008
- A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cellsBiochemical Journal, 2007
- Control of matrix metalloproteinase catalytic activityMatrix Biology, 2007
- NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβCell, 2007
- Plasminogen activation independent of uPA and tPA maintains wound healing in gene‐deficient miceThe EMBO Journal, 2006
- Fibroblasts in cancerNature Reviews Cancer, 2006
- Cytoplasmic and nuclear interaction between Rb family proteins and PAI-2: a physiological crosstalk in human corneal and conjunctival epithelial cellsCell Death & Differentiation, 2006
- Crystal Structure of the Complex of Plasminogen Activator Inhibitor 2 with a Peptide Mimicking the Reactive Center LoopJournal of Biological Chemistry, 2001
- Cellular Distribution and Clinical Value of Urokinase-Type Plasminogen Activator, Its Receptor, and Plasminogen Activator Inhibitor-2 in Esophageal Squamous Cell CarcinomaThe American Journal of Pathology, 2000
- The Hallmarks of CancerCell, 2000